{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T17:17:23Z","timestamp":1790443043449,"version":"4.1.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"36","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.vaccine.2019.06.074","type":"journal-article","created":{"date-parts":[[2019,6,29]],"date-time":"2019-06-29T07:15:33Z","timestamp":1561792533000},"page":"5485-5490","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["The continuing search for an addiction vaccine"],"prefix":"10.1016","volume":"37","author":[{"given":"M. Heval","family":"Ozgen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart","family":"Blume","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2019.06.074_b0005","doi-asserted-by":"crossref","first-page":"4158","DOI":"10.1016\/j.vaccine.2015.04.035","article-title":"Review of vaccine hesitancy: rationale, remit and methods","volume":"33","author":"Schuster","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.06.074_b0010","series-title":"Immunization. How vaccines became controversial","author":"Blume","year":"2008"},{"key":"10.1016\/j.vaccine.2019.06.074_b0015","series-title":"Beginnings count. The technological imperative in American health care","author":"Rothman","year":"1997"},{"issue":"9","key":"10.1016\/j.vaccine.2019.06.074_b0020","first-page":"22","article-title":"We can conquer drug addiction","volume":"33","author":"Leshner","year":"1999","journal-title":"Futurist"},{"issue":"12","key":"10.1016\/j.vaccine.2019.06.074_b0025","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1586\/era.12.147","article-title":"Breast cancer immunobiology driving immunotherapy: vaccines and immune checkpoint blockade","volume":"12","author":"Emens","year":"2012","journal-title":"Expert Rev Anticancer Ther"},{"issue":"1","key":"10.1016\/j.vaccine.2019.06.074_b0030","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1586\/14760584.2014.869420","article-title":"Recent progress toward development of vaccines against conception","volume":"13","author":"Naz","year":"2014","journal-title":"Expert Rev Vaccines"},{"issue":"1","key":"10.1016\/j.vaccine.2019.06.074_b0035","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1080\/14712598.2019.1554646","article-title":"A vaccine against Alzheimer's disease: anything left but faith?","volume":"19","author":"Bachmann","year":"2019","journal-title":"Expert Opin Biol Ther"},{"issue":"4","key":"10.1016\/j.vaccine.2019.06.074_b0040","doi-asserted-by":"crossref","first-page":"887","DOI":"10.4161\/hv.27537","article-title":"Obesity vaccines","volume":"10","author":"Monteiro","year":"2014","journal-title":"Human Vaccines Immunother"},{"key":"10.1016\/j.vaccine.2019.06.074_b0045","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3389\/fpsyt.2013.00141","article-title":"Addiction and the brain disease fallacy","volume":"4","author":"Satel","year":"2014","journal-title":"Front Psychiatry"},{"key":"10.1016\/j.vaccine.2019.06.074_b0050","series-title":"Slaying the dragon: the history of addiction treatment and recovery in America","author":"White","year":"1998"},{"issue":"1","key":"10.1016\/j.vaccine.2019.06.074_b0055","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1057\/biosoc.2009.3","article-title":"The NIDA brain disease paradigm: history, resistance and spinoffs","volume":"5","author":"Courtwright","year":"2010","journal-title":"BioSocieties"},{"issue":"3937","key":"10.1016\/j.vaccine.2019.06.074_b0060","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1126\/science.168.3937.1347","article-title":"Morphine: radioimmunoassay","volume":"168","author":"Spector","year":"1970","journal-title":"Science"},{"issue":"4067","key":"10.1016\/j.vaccine.2019.06.074_b0065","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1126\/science.178.4067.1290","article-title":"Evidence for active immunity to morphine in mice","volume":"178","author":"Berkowitz","year":"1972","journal-title":"Science"},{"issue":"5485","key":"10.1016\/j.vaccine.2019.06.074_b0070","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/252708a0","article-title":"Changes in heroin self-administration by a rhesus monkey after morphine immunisation","volume":"252","author":"Bonese","year":"1974","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.vaccine.2019.06.074_b0075","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.4049\/jimmunol.114.4.1363","article-title":"Delayed clearance of morphine from the circulation of rabbits immunized with morphine-6-hemisuccinate bovine serum albumin","volume":"114","author":"Hill","year":"1975","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2019.06.074_b0080","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.pbb.2009.01.015","article-title":"Immunopharmacotherapy: vaccination strategies as a treatment for drug abuse and dependence","volume":"92","author":"Moreno","year":"2009","journal-title":"Pharmacol Biochem Behav"},{"issue":"1","key":"10.1016\/j.vaccine.2019.06.074_b0085","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/clpt.2011.281","article-title":"Vaccines against drug abuse","volume":"91","author":"Shen","year":"2012","journal-title":"Clin Pharmacol Ther"},{"issue":"7","key":"10.1016\/j.vaccine.2019.06.074_b0090","doi-asserted-by":"crossref","first-page":"505","DOI":"10.2165\/00023210-200115070-00001","article-title":"Vaccines against nicotine: how effective are they likely to be in preventing smoking?","volume":"15","author":"Vocci","year":"2001","journal-title":"CNS Drugs"},{"issue":"1","key":"10.1016\/j.vaccine.2019.06.074_b0095","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0091-3057(99)00206-3","article-title":"A nicotine conjugate vaccine reduces nicotine distribution to brain and attenuates its behavioral and cardiovascular effects in rats","volume":"65","author":"Pentel","year":"2000","journal-title":"Pharmacol Biochem Behav"},{"issue":"11","key":"10.1016\/j.vaccine.2019.06.074_b0100","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1080\/14760584.2017.1378577","article-title":"Current status and future prospects for the development of substance abuse vaccines","volume":"16","author":"Heekin","year":"2017","journal-title":"Expert Rev Vaccines"},{"issue":"8","key":"10.1016\/j.vaccine.2019.06.074_b0105","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1111\/add.12569","article-title":"Nicotine vaccination\u2013does it have a future?","volume":"109","author":"van Schayck","year":"2014","journal-title":"Addiction"},{"issue":"9","key":"10.1016\/j.vaccine.2019.06.074_b0110","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1038\/npp.2015.64","article-title":"Effects of the nanoparticle-based vaccine, SEL-068, on nicotine discrimination in squirrel monkeys","volume":"40","author":"Desai","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.vaccine.2019.06.074_b0115","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.biomaterials.2016.08.028","article-title":"The next-generation nicotine vaccine: a novel and potent hybrid nanoparticle-based nicotine vaccine","volume":"106","author":"Hu","year":"2016","journal-title":"Biomaterials"},{"issue":"6558","key":"10.1016\/j.vaccine.2019.06.074_b0120","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/378727a0","article-title":"Suppression of psychoactive effects of cocaine by active immunization","volume":"378","author":"Carrera","year":"1995","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.vaccine.2019.06.074_b0125","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0376-8716(97)00121-X","article-title":"Development of a therapeutic vaccine for the treatment of cocaine addiction","volume":"48","author":"Fox","year":"1997","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"10.1016\/j.vaccine.2019.06.074_b0130","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.biopsych.2005.04.032","article-title":"Vaccine pharmacotherapy for the treatment of cocaine dependence","volume":"58","author":"Martell","year":"2005","journal-title":"Biol Psychiatry"},{"issue":"140","key":"10.1016\/j.vaccine.2019.06.074_b0135","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.drugalcdep.2014.04.003","article-title":"Vaccine for cocaine dependence: a randomized double-blind placebo-controlled efficacy trial","volume":"1","author":"Kosten","year":"2014","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.vaccine.2019.06.074_b0140","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.pbb.2016.09.008","article-title":"Efficacy of an adenovirus-based anti-cocaine vaccine to reduce cocaine self-administration and reacqusition using a choice procedure in rhesus macaques","volume":"150\u2013151","author":"Evans","year":"2016","journal-title":"Pharmacol Biochem Behav."},{"key":"10.1016\/j.vaccine.2019.06.074_b0145","unstructured":"Cornell Weill press release Anti-Cocaine vaccine approved for clinical study in humans\u2019 https:\/\/news.weill.cornell.edu\/news\/2016\/08\/anti-cocaine-vaccine-approved-for-clinical-study-in-humans (accessed 27 October 2017)."},{"issue":"2","key":"10.1016\/j.vaccine.2019.06.074_b0150","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0378-4347(97)00527-6","article-title":"Immunological analysis of methamphetamine antibody and its use for the detection of methamphetamine by capillary electrophoresis with laser-induced fluorescence","volume":"705","author":"Choi","year":"1998","journal-title":"J Chromatogr B Biomed Sci Appl"},{"key":"10.1016\/j.vaccine.2019.06.074_b0155","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.intimp.2016.03.028","article-title":"Optimization of a methamphetamine conjugate vaccine for antibody production in mice","volume":"35","author":"Stevens","year":"2016","journal-title":"Int Immunopharmacol"},{"issue":"2","key":"10.1016\/j.vaccine.2019.06.074_b0160","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/ajad.12867","article-title":"Preclinical efficacy of an anti-methamphetamine vaccine using E6020 adjuvant","volume":"28","author":"Arora","year":"2019","journal-title":"Am J Addict"},{"issue":"16","key":"10.1016\/j.vaccine.2019.06.074_b0165","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.1016\/j.vaccine.2006.01.047","article-title":"A novel bivalent morphine\/heroin vaccine that prevents relapse to heroin addiction in rodents","volume":"24","author":"Anton","year":"2006","journal-title":"Vaccine"},{"issue":"14","key":"10.1016\/j.vaccine.2019.06.074_b0170","doi-asserted-by":"crossref","first-page":"5195","DOI":"10.1021\/jm200461m","article-title":"A vaccine strategy that induces protective immunity against heroin","volume":"54","author":"Stowe","year":"2011","journal-title":"J Med Chem"},{"issue":"25","key":"10.1016\/j.vaccine.2019.06.074_b0175","doi-asserted-by":"crossref","first-page":"8601","DOI":"10.1021\/jacs.7b03334","article-title":"Development of a clinically viable heroin vaccine","volume":"139","author":"Bremer","year":"2017","journal-title":"J Am Chem Soc"},{"issue":"1","key":"10.1016\/j.vaccine.2019.06.074_b0180","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1176\/appi.ajp.2015.15020262","article-title":"Prescription opioid misuse, abuse, and treatment in the United States: an update","volume":"173","author":"Brady","year":"2016","journal-title":"Am J Psychiatry"},{"issue":"11","key":"10.1016\/j.vaccine.2019.06.074_b0185","doi-asserted-by":"crossref","first-page":"3772","DOI":"10.1002\/anie.201511654","article-title":"Combatting synthetic designer opioids: a conjugate vaccine ablates lethal doses of fentanyl class drugs","volume":"55","author":"Bremer","year":"2016","journal-title":"Angew Chem Int Ed Engl"},{"issue":"12","key":"10.1016\/j.vaccine.2019.06.074_b0190","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1371\/journal.pone.0184876","article-title":"Safety and efficacy of an oxycodone vaccine: Addressing some of the unique considerations posed by opioid abuse","volume":"12","author":"Raleigh","year":"2017","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.vaccine.2019.06.074_b0195","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.tips.2018.08.001","article-title":"Immunopharmacotherapies for Treating Opioid Use Disorder","volume":"39","author":"Banks","year":"2018","journal-title":"Trends Pharmacol Sci"},{"issue":"11","key":"10.1016\/j.vaccine.2019.06.074_b0200","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1517\/17460441.2014.951631","article-title":"Medications development for substance-use disorders: contextual influences (dis)incentivizing pharmaceutical-industry positioning","volume":"9","author":"Janero","year":"2014","journal-title":"Expert Opin Drug Discov"},{"issue":"18","key":"10.1016\/j.vaccine.2019.06.074_b0205","first-page":"1798","article-title":"The role of science in the opioid crisis","volume":"377","author":"Volkow","year":"2017","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.vaccine.2019.06.074_b0210","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S2215-0366(15)00236-9","article-title":"Brain disease model of addiction: why is it so controversial?","volume":"2","author":"Volkow","year":"2015","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.vaccine.2019.06.074_b0215","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1146\/annurev-publhealth-031914-122957","article-title":"The prescription opioid and heroin crisis: a public health approach to an epidemic of addiction","volume":"36","author":"Kolodny","year":"2015","journal-title":"Ann Rev Publ Health"},{"issue":"1","key":"10.1016\/j.vaccine.2019.06.074_b0220","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1177\/0033354917743500","article-title":"Where next for opioids and the law? Despair, harm reduction, lawsuits, and regulatory reform","volume":"133","author":"Burris","year":"2018","journal-title":"Public Health Rep"},{"issue":"48","key":"10.1016\/j.vaccine.2019.06.074_b0225","doi-asserted-by":"crossref","first-page":"6545","DOI":"10.1016\/j.vaccine.2015.09.079","article-title":"Is immunotherapy an opportunity for effective treatment of drug addiction?","volume":"33","author":"Zalewska-Kaszubska","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.06.074_b0230","unstructured":"Council of Europe Experts Committee on Ethical Issues and Professional Standards, Ethical questions raised by immunotherapy of addiction. The example of the \u2018vaccine\u2019 against cocaine. <https:\/\/rm.coe.int\/publication-ethical-questions-raised-by-immunotherapy-of-addiction-the\/1680746124 2010> (accessed 31 October 2017)."},{"issue":"1","key":"10.1016\/j.vaccine.2019.06.074_b0235","doi-asserted-by":"crossref","first-page":"5","DOI":"10.15252\/embr.201745322","article-title":"Vaccines to combat the opioid crisis: Vaccines that prevent opioids and other substances of abuse from entering the brain could effectively treat addiction and abuse","volume":"19","author":"Olson","year":"2018","journal-title":"EMBO Rep"},{"issue":"3","key":"10.1016\/j.vaccine.2019.06.074_b0240","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0376-8716(97)00075-6","article-title":"Immunization for prevention and treatment of cocaine abuse: legal and ethical implications","volume":"48","author":"Cohen","year":"1997","journal-title":"Drug Alcohol Depend"},{"issue":"7","key":"10.1016\/j.vaccine.2019.06.074_b0245","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1111\/j.1360-0443.2012.03812.x","article-title":"What are the public policy implications of a neurobiological view of addiction?","volume":"107","author":"Gartner","year":"2012","journal-title":"Addiction"},{"issue":"3","key":"10.1016\/j.vaccine.2019.06.074_b0250","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/YCO.0b013e328345922b","article-title":"Ethical and policy issues in using vaccines to treat and prevent cocaine and nicotine dependence","volume":"24","author":"Hall","year":"2011","journal-title":"Curr Opin Psychiatry"},{"issue":"1","key":"10.1016\/j.vaccine.2019.06.074_b0255","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s11673-017-9834-5","article-title":"Ethical Implications in vaccine pharmacotherapy for treatment and prevention of drug of abuse dependence","volume":"15","author":"Carfora","year":"2018","journal-title":"J Bioeth Inq"},{"issue":"6","key":"10.1016\/j.vaccine.2019.06.074_b0260","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/ni.2321","article-title":"Immune to addiction: the ethical dimensions of vaccines against substance abuse","volume":"13","author":"Young","year":"2012","journal-title":"Nat Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19308515?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19308515?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:35:17Z","timestamp":1759401317000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X19308515"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":52,"journal-issue":{"issue":"36","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["S0264410X19308515"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.06.074","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The continuing search for an addiction vaccine","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.06.074","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}